GlassScriptPhysician profile
Rami M Ausi
NPI 1851508691
$9,101.23
in general payments reported to CMS, 2019-2025
51 companies · $2,125 in 2025
The $2,125 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $624 · 2021: $1,033 · 2022: $1,412 · 2023: $963 · 2024: $1,756 · 2025: $2,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,813 · Education: $31.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,812.62 |
| Education | $31.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,397.22 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Lilly USA, LLC | $872.26 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Pfizer INC. | $759.32 | 2023-2025 | |
| Amgen INC. | $566.69 | 2019-2025 | Aimovig, Uplizna |
| Teva Pharmaceuticals USA, INC. | $544.99 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Acadia Pharmaceuticals INC | $486.66 | 2019-2025 | Nuplazid, Daybue |
| Eisai INC. | $446.94 | 2022-2025 | |
| Sk Life Science, INC. | $355.37 | 2020-2025 | |
| Genzyme Corporation | $284.99 | 2019-2023 | |
| Biogen, INC. | $278.56 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Supernus Pharmaceuticals, INC. | $262.86 | 2019-2020 | |
| Allergan, INC. | $252.35 | 2019-2022 | |
| Emd Serono, INC. | $200.15 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $185.49 | 2024-2025 | Ponvory |
| Ucb, INC. | $177.71 | 2019-2024 | Briviact, Zilbrysq, Rystiggo |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Ausi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.